Key result
Higher TG/HDL-C ratio linked to ~17% greater OSA risk per unit increase.
Why the study?
Obstructive sleep apnea is associated with dyslipidemia and cardiovascular morbidity, prompting investigation into the triglyceride-to-high-density lipoprotein cholesterol ratio as a biomarker for OSA prevalence.
Is the TG/HDL-C ratio associated with the prevalence of obstructive sleep apnea in the adult US population?
Cross-Sectional (n=3,270)
Is the TG/HDL-C ratio associated with the prevalence of obstructive sleep apnea in the adult US population?
Effect estimate: OR 1.17 (95% CI 1.00-1.35)
p-value: p=0.045
The TG/HDL-C ratio is a superior predictor of obstructive sleep apnea risk compared to individual lipid indices, suggesting its potential utility as a composite biomarker for early OSA detection.
Hypothesis-generating for TG/HDL-C as OSA biomarker; prospective validation required before clinical adoption.
Background Obstructive sleep apnea (OSA) is associated with dyslipidemia, neurocognitive impairment, and cardiovascular morbidity. This study investigates the triglyceride-to-high-density lipoprotein cholesterol ratio (TG/HDL-C) as a composite biomarker for OSA prevalence, with implications for mitigating OSA-associated complications through metabolic modulation. Methods A nationally representative cohort of 3,270 adults (NHANES 2015–2018) was analyzed using weighted multivariate logistic regression. Restricted cubic splines (RCS) modeled nonlinear associations, while receiver operating characteristic (ROC) curves evaluated predictive performance against conventional lipid indices (TG, HDL-C) and composite lipid indices (TG/HDL-C, NHHR). The DeLong test further compares the predictive efficacy between models. The differences between groups in predicting OSA based on TG/HDL-C levels were further examined via subgroup analysis. Results Significant differences in lipid profiles were observed between OSA and non-OSA cohorts ( p < 0.001). Each unit increase in TG/HDL-C conferred a 17% elevated OSA risk [OR = 1.17; 95% CI: 1.00–1.35; p = 0.045], with a nonlinear dose–response relationship ( p for interaction = 0.017). TG/HDL-C demonstrated superior predictive accuracy (AUC = 0.589) versus NHHR (AUC = 0.572). Subgroup analyses indicated that TG/HDL-C as an indicator of OSA varied by the family income to poverty ratio (PIR) group, as well as among congestive heart failure and angina populations ( p for interaction < 0.05). Conclusion This study demonstrates that the TG/HDL-C ratio is a superior predictor of OSA risk compared to TG and NHHR. These findings underscore the clinical utility of composite lipid indices TG/HDL-C for early OSA detection and targeted intervention.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2025) conducted a cross-sectional in Obstructive sleep apnea (n=3,270). TG/HDL-C ratio vs. Lower TG/HDL-C ratio was evaluated on Prevalence of obstructive sleep apnea (OSA) (OR 1.17, 95% CI 1.00-1.35, p=0.045). Each unit increase in the TG/HDL-C ratio was independently associated with a 17% elevated risk of obstructive sleep apnea (OR 1.17) in the adult US population.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: